Thus, the evaluation of CD55 using preoperative EUS-guided cyst fluid is a natural next step in validating the diagnostic value of CD55 as a marker for IPMN dysplasia. The gene discussed is CD55; the disease is pancreatic intraductal papillary-mucinous neoplasm.